Experts Aim to Use Brown Fat to Burn Fat More Effectively

Studies presented at the 67th German Congress of Endocrinology discussed the potential of targeting brown fat tissue for fat burning, as obesity rates are high in Germany. While current treatments focus on reducing energy intake, a more sustainable option could be to increase energy expenditure by activating brown fat tissue. Brown fat burns calories to…

Read More

Lupin bags USFDA nod for Eslicarbazepine Acetate Tablets for partial-onset seizures

Lupin has received approval from the US Food and Drug Administration for Eslicarbazepine Acetate Tablets, used for treating partial-onset seizures. The company’s latest pharmaceutical offering will help in managing this specific type of seizure disorder. Lupin’s achievement signifies another milestone in its commitment to providing effective treatments for various medical conditions. Additionally, the company’s use…

Read More

Almost 875,000 unregulated medicines detained by health authorities in 2023

Sedatives and anabolic steroids made up more than half of the nearly 875,000 units of illegal medicines seized by health authorities last year. The Health Products Regulatory Authority (HPRA) warned of the health risks of buying prescription drugs online or from unauthorized sources. The detained medications also included erectile dysfunction treatments, analgesics, stimulants, and cosmetic…

Read More

Higher SBP in Midlife Associated With Later Risk of AF

A study in the Journal of the American Heart Association found that increased systolic blood pressure, pulse pressure, and mean arterial blood pressure in midlife are associated with a higher risk of atrial fibrillation in later life. The study, conducted with participants from the ARIC study, showed that elevated blood pressure was linked to a…

Read More

Brightside Health secures $33 million in Series C funding

San Francisco-based telemental health company Brightside Health secured $33 million in Series C funding from S32 and investors including Kennedy Lewis, Time BioVentures, and Anne Wojcicki. The funding brings their total raised amount to $100 million. The company provides care for anxiety, depression, and other mood disorders through a Crisis Care psychiatry platform. The funding…

Read More

The Supreme Court and the Abortion Pill

The Supreme Court appears unlikely to restrict availability of the abortion pill mifepristone in its first abortion case since Roe v. Wade, with more abortion-related cases on the horizon. Republicans target health programs like Medicare and Medicaid, giving Democrats an advantage. Conservative justices express skepticism about challenges to mifepristone, which could impact the drug’s safety…

Read More

mifepristone case, GLP-1s, & Chinese biotech

“The Readout LOUD” is a biotech podcast that covers various topics including who can sue the FDA, the impact of a Supreme Court case on medication abortion and new medicines, and the implications of a trade war on the pharmaceutical industry. The podcast also discusses contrarian views on new obesity treatments, efforts to ban Chinese…

Read More
error: Content is protected !!